Enanta Pharmaceuticals
ENTA
ENTA
154 hedge funds and large institutions have $856M invested in Enanta Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 55 increasing their positions, 59 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
154
Holders Change
-15
Holders Change %
-8.88%
% of All Funds
2.6%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
10
Increased
55
Reduced
59
Closed
21
Calls
$7.16M
Puts
$619K
Net Calls
+$6.54M
Net Calls Change
+$3.81M
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$80.3M |
| 2 |
2
Invesco
Atlanta,
Georgia
|
$23.6M |
| 3 |
PBA
3
Paradigm Biocapital Advisors
New York
|
$7.01M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$8.4M |
| 5 |
5
Fidelity Investments
Boston,
Massachusetts
|
$16.6M |
